Publication Information

{'id': 'https://openalex.org/W4248852202', 'doi': 'https://doi.org/10.1158/1538-7445.am2019-1295', 'title': 'Abstract 1295: First-in-field small molecule inhibitors targeting BRN2 as a therapeutic strategy for small cell prostate cancer', 'display_name': 'Abstract 1295: First-in-field small molecule inhibitors targeting BRN2 as a therapeutic strategy for small cell prostate cancer', 'publication_year': 2019, 'publication_date': '2019-07-01', 'ids': {'openalex': 'https://openalex.org/W4248852202', 'doi': 'https://doi.org/10.1158/1538-7445.am2019-1295'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2019-1295', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5056176506', 'display_name': 'Daksh Thaper', 'orcid': None}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Daksh Thaper', 'raw_affiliation_strings': ['1Vancouver Prostate Ctr., Vancouver, British Columbia, Canada;'], 'affiliations': [{'raw_affiliation_string': '1Vancouver Prostate Ctr., Vancouver, British Columbia, Canada;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5055762119', 'display_name': 'Ravi S. N. Munuganti', 'orcid': 'https://orcid.org/0009-0006-5084-510X'}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Ravi Munuganti', 'raw_affiliation_strings': ['1Vancouver Prostate Ctr., Vancouver, British Columbia, Canada;'], 'affiliations': [{'raw_affiliation_string': '1Vancouver Prostate Ctr., Vancouver, British Columbia, Canada;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5090242120', 'display_name': 'Shaghayegh Nouruzi', 'orcid': None}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Shaghayegh Nouruzi', 'raw_affiliation_strings': ['1Vancouver Prostate Ctr., Vancouver, British Columbia, Canada;'], 'affiliations': [{'raw_affiliation_string': '1Vancouver Prostate Ctr., Vancouver, British Columbia, Canada;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5049699271', 'display_name': 'Sahil Kumar', 'orcid': 'https://orcid.org/0000-0002-4868-0741'}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Sahil Kumar', 'raw_affiliation_strings': ['1Vancouver Prostate Ctr., Vancouver, British Columbia, Canada;'], 'affiliations': [{'raw_affiliation_string': '1Vancouver Prostate Ctr., Vancouver, British Columbia, Canada;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100327316', 'display_name': 'Soojin Kim', 'orcid': 'https://orcid.org/0009-0008-4092-8942'}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Soojin Kim', 'raw_affiliation_strings': ['1Vancouver Prostate Ctr., Vancouver, British Columbia, Canada;'], 'affiliations': [{'raw_affiliation_string': '1Vancouver Prostate Ctr., Vancouver, British Columbia, Canada;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5034291975', 'display_name': 'Olena Sivak', 'orcid': None}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Olena Sivak', 'raw_affiliation_strings': ['1Vancouver Prostate Ctr., Vancouver, British Columbia, Canada;'], 'affiliations': [{'raw_affiliation_string': '1Vancouver Prostate Ctr., Vancouver, British Columbia, Canada;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5065225841', 'display_name': 'A.H. Aguda', 'orcid': 'https://orcid.org/0000-0001-5187-3264'}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Adeleke Aguda', 'raw_affiliation_strings': ['1Vancouver Prostate Ctr., Vancouver, British Columbia, Canada;'], 'affiliations': [{'raw_affiliation_string': '1Vancouver Prostate Ctr., Vancouver, British Columbia, Canada;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5036640737', 'display_name': 'Dwaipayan Ganguli', 'orcid': None}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Dwaipayan Ganguli', 'raw_affiliation_strings': ['1Vancouver Prostate Ctr., Vancouver, British Columbia, Canada;'], 'affiliations': [{'raw_affiliation_string': '1Vancouver Prostate Ctr., Vancouver, British Columbia, Canada;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5055642554', 'display_name': 'Sepideh Vahid', 'orcid': None}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Sepideh Vahid', 'raw_affiliation_strings': ['1Vancouver Prostate Ctr., Vancouver, British Columbia, Canada;'], 'affiliations': [{'raw_affiliation_string': '1Vancouver Prostate Ctr., Vancouver, British Columbia, Canada;', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5057570241', 'display_name': 'Loredana Puca', 'orcid': 'https://orcid.org/0000-0002-0895-1519'}, 'institutions': [{'id': 'https://openalex.org/I205783295', 'display_name': 'Cornell University', 'ror': 'https://ror.org/05bnh6r87', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I205783295']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Loredana Puca', 'raw_affiliation_strings': ['2Weill Cornell Medical College, New York, NY;'], 'affiliations': [{'raw_affiliation_string': '2Weill Cornell Medical College, New York, NY;', 'institution_ids': ['https://openalex.org/I205783295']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5047882814', 'display_name': 'Himisha Beltran', 'orcid': 'https://orcid.org/0000-0003-3259-2226'}, 'institutions': [{'id': 'https://openalex.org/I4210117453', 'display_name': 'Dana-Farber Cancer Institute', 'ror': 'https://ror.org/02jzgtq86', 'country_code': 'US', 'type': 'facility', 'lineage': ['https://openalex.org/I4210117453']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Himisha Beltran', 'raw_affiliation_strings': ['3Dana Farber Cancer Institute, Boston, MA.'], 'affiliations': [{'raw_affiliation_string': '3Dana Farber Cancer Institute, Boston, MA.', 'institution_ids': ['https://openalex.org/I4210117453']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5081653545', 'display_name': 'Amina Zoubeidi', 'orcid': 'https://orcid.org/0000-0002-0498-142X'}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Amina Zoubeidi', 'raw_affiliation_strings': ['1Vancouver Prostate Ctr., Vancouver, British Columbia, Canada;'], 'affiliations': [{'raw_affiliation_string': '1Vancouver Prostate Ctr., Vancouver, British Columbia, Canada;', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.19, 'has_fulltext': False, 'cited_by_count': 2, 'citation_normalized_percentile': {'value': 0.656464, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 69, 'max': 74}, 'biblio': {'volume': '79', 'issue': '13_Supplement', 'first_page': '1295', 'last_page': '1295'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.988, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.988, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12334', 'display_name': 'Lung Cancer Research Studies', 'score': 0.9844, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.9825, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/enzalutamide', 'display_name': 'Enzalutamide', 'score': 0.62186545}], 'concepts': [{'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.68080175}, {'id': 'https://openalex.org/C2777933648', 'wikidata': 'https://www.wikidata.org/wiki/Q21114866', 'display_name': 'SOX2', 'level': 4, 'score': 0.6297786}, {'id': 'https://openalex.org/C2776551883', 'wikidata': 'https://www.wikidata.org/wiki/Q1996756', 'display_name': 'Enzalutamide', 'level': 5, 'score': 0.62186545}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.44234902}, {'id': 'https://openalex.org/C2780192828', 'wikidata': 'https://www.wikidata.org/wiki/Q181257', 'display_name': 'Prostate cancer', 'level': 3, 'score': 0.4370514}, {'id': 'https://openalex.org/C61367390', 'wikidata': 'https://www.wikidata.org/wiki/Q416601', 'display_name': 'Androgen receptor', 'level': 4, 'score': 0.43450558}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.3968534}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.3174767}, {'id': 'https://openalex.org/C86339819', 'wikidata': 'https://www.wikidata.org/wiki/Q407384', 'display_name': 'Transcription factor', 'level': 3, 'score': 0.30242026}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.16108954}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.11261913}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2019-1295', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.81, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4362495275', 'https://openalex.org/W4362495086', 'https://openalex.org/W4361849348', 'https://openalex.org/W4361849260', 'https://openalex.org/W4361817127', 'https://openalex.org/W3044054345', 'https://openalex.org/W2927728931', 'https://openalex.org/W2767048879', 'https://openalex.org/W2737056430', 'https://openalex.org/W2177175549'], 'abstract_inverted_index': {'Abstract': [0], 'Introduction:': [1], 'Resistance': [2], 'to': [3, 66, 98, 144, 230, 250, 286, 309], 'newly': [4], 'developed': [5], 'androgen': [6], 'receptor': [7], 'pathway': [8], 'inhibitors': [9, 162, 262, 354], '(ARPIs),': [10], 'such': [11], 'as': [12, 119, 206, 208, 357], 'Enzalutamide': [13], '(ENZ),': [14], 'rapidly': [15], 'emerges': [16], 'and': [17, 46, 127, 134, 163, 173, 241, 267, 294, 312], 'patients': [18, 29, 317], 'generally': [19], 'die': [20], 'within': [21, 256], 'two': [22], 'years.': [23], 'In': [24], 'particular,': [25], 'a': [26, 76, 120, 141, 289, 358], 'subset': [27], 'of': [28, 82, 107, 125, 155, 169, 196, 214, 248, 292, 302, 314, 322, 369], 'who': [30], 'relapse': [31], 'following': [32], 'ARPI': [33], 'therapy': [34], 'exhibit': [35], 'lineage': [36], 'switching': [37], 'whereby': [38], 'tumours': [39], 'shed': [40], 'their': [41], 'dependence': [42], 'on': [43], 'AR': [44], 'signaling': [45], 'emerge': [47], 'with': [48, 244], 'neuroendocrine': [49, 56, 146], 'features.': [50], 'These': [51], 'tumours,': [52], 'termed': [53], 'treatment': [54, 68, 307], 'induced': [55], 'prostate': [57, 323, 364], 'cancer': [58, 365], '(t-NEPC),': [59], 'carry': [60], 'an': [61], 'extremely': [62], 'poor': [63], 'prognosis': [64], 'and,': [65], 'date,': [67], 'remains': [69], 'decades': [70], 'old': [71], 'cytotoxic': [72], 'chemotherapy': [73], 'which': [74], 'carries': [75], 'short-lived': [77], 'response': [78], 'at': [79], 'the': [80, 96, 114, 153, 251, 282, 296, 300, 306, 370], 'cost': [81], 'significant': [83], 'toxicity.': [84], 'Therefore,': [85], 'targeted': [86, 100, 303], 'therapies': [87, 275, 304], 'for': [88, 102, 277, 299, 316, 361, 373], 'this': [89, 103], 'deadly': [90, 320], 'disease': [91, 105], 'are': [92], 'desperately': [93], 'needed.': [94], 'Thus,': [95], 'need': [97], 'develop': [99], 'treatments': [101], 'devastating': [104], 'is': [106, 140], 'paramount': [108], 'importance.': [109], 'Recently': [110], 'our': [111, 220], 'group': [112], 'identified': [113], 'neural': [115], 'transcription': [116], 'factor': [117], 'BRN2': [118, 139, 156, 170, 197, 224, 227, 249, 261, 356], 'major': [121], 'clinically': [122], 'relevant': [123], 'driver': [124, 291], 'NEPC': [126, 192, 203, 236, 269], 'aggressive': [128], 'tumor': [129], 'growth,': [130], 'both': [131], 'in': [132, 135, 181, 190, 202, 209, 222, 235, 271], 'vitro': [133], 'vivo,': [136], 'suggesting': [137], 'targeting': [138, 355], 'promising': [142], 'strategy': [143, 360], 'prevent': [145], 'differentiation': [147], 'or': [148], 'treat': [149], 'NEPC.': [150, 280], 'Methods:': [151], 'Study': [152], 'effects': [154], 'inhibition': [157], 'using': [158, 219], 'siRNA,': [159], 'small': [160, 352, 362], 'molecule': [161, 353], 'CRISPR': [164], 'K/O': [165], 'models.': [166], 'Results:': [167], 'Inhibition': [168], 'by': [171, 174, 253], 'siRNA': [172], 'CRISPR/Cas9': [175], 'knockout': [176], 'drastically': [177], 'reduced': [178, 246, 268], 'cell': [179, 184, 204, 363], 'proliferation': [180, 270], '42DENZR': [182], '(NEPC)': [183], 'lines.': [185], 'This': [186, 216], 'data': [187], 'was': [188, 217], 're-capitulated': [189], 'human': [191], 'NCI-H660': [193], 'cells.': [194], 'Loss': [195], 'initiated': [198], 'drastic': [199], 'epigenetic': [200], 'changes': [201], 'lines': [205], 'well': [207], 'G1': [210], 'arrest': [211], 'through': [212], 'up-regulation': [213], 'CDKN1A/1B.': [215], 'confirmed': [218], 'first': [221], 'field': [223], 'inhibitors.': [225], 'Targeting': [226], 'also': [228], 'lead': [229], 'downregulation': [231], 'several': [232], 'known': [233], 'targets': [234], 'like': [237], 'EZH2,': [238], 'AURKA,': [239], 'SOX2': [240], 'Peg10.': [242], 'Treatment': [243], 'BRN2i': [245], 'recruitment': [247], 'chromatin': [252], 'approximately': [254], '93%': [255], '16': [257], 'hours.': [258], 'Moreover,': [259], 'these': [260], 'displayed': [263], 'adequate': [264], 'pharmacokinetic': [265], 'properties': [266], 'vivo.': [272], 'Conclusion:': [273], 'No': [274], 'exist': [276], 'highly': [278], 'lethal': [279], 'Hence,': [281], 'described': [283], 'work': [284], 'aims': [285], 'verify': [287], 'BRN2,': [288], 'central': [290], 'NEPC,': [293], 'lay': [295], 'pre-clinical': [297], 'foundation': [298], 'integration': [301], 'into': [305], 'landscape': [308], 'improve': [310], 'survival': [311], 'quality': [313], 'life': [315], 'suffering': [318], 'from': [319], 'form': [321], 'cancer.': [324], 'Citation': [325], 'Format:': [326], 'Daksh': [327], 'Thaper,': [328], 'Ravi': [329], 'Munuganti,': [330], 'Shaghayegh': [331], 'Nouruzi,': [332], 'Sahil': [333], 'Kumar,': [334], 'Soojin': [335], 'Kim,': [336], 'Olena': [337], 'Sivak,': [338], 'Adeleke': [339], 'Aguda,': [340], 'Dwaipayan': [341], 'Ganguli,': [342], 'Sepideh': [343], 'Vahid,': [344], 'Loredana': [345], 'Puca,': [346], 'Himisha': [347], 'Beltran,': [348], 'Amina': [349], 'Zoubeidi.': [350], 'First-in-field': [351], 'therapeutic': [359], '[abstract].': [366], 'In:': [367], 'Proceedings': [368], 'American': [371], 'Association': [372], 'Cancer': [374, 388], 'Research': [375], 'Annual': [376], 'Meeting': [377], '2019;': [378], '2019': [379], 'Mar': [380], '29-Apr': [381], '3;': [382], 'Atlanta,': [383], 'GA.': [384], 'Philadelphia': [385], '(PA):': [386], 'AACR;': [387], 'Res': [389], '2019;79(13': [390], 'Suppl):Abstract': [391], 'nr': [392], '1295.': [393]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4248852202', 'counts_by_year': [{'year': 2019, 'cited_by_count': 1}], 'updated_date': '2024-12-12T17:40:07.757096', 'created_date': '2022-05-12'}